🇺🇸 Fluorouracil + folinic acid in United States
35 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 35
Most-reported reactions
- Nausea — 7 reports (20%)
- Dyspnoea — 5 reports (14.29%)
- Malignant Neoplasm Progression — 4 reports (11.43%)
- Confusional State — 3 reports (8.57%)
- Dehydration — 3 reports (8.57%)
- Diarrhoea — 3 reports (8.57%)
- Platelet Count Decreased — 3 reports (8.57%)
- Vomiting — 3 reports (8.57%)
- Abdominal Pain — 2 reports (5.71%)
- Asthenia — 2 reports (5.71%)
Other Oncology approved in United States
Frequently asked questions
Is Fluorouracil + folinic acid approved in United States?
Fluorouracil + folinic acid does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Fluorouracil + folinic acid in United States?
Odense University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.